Medicon Valley Alliance in collaboration with ICON plc invites you to join leading industry experts on biomarker research for a unique, dynamic and interactive evening.
Science after Hours is a “moving round table” networking event where you can learn and engage with leading biomarker experts and industry colleagues about compelling scientific insights on the use of biomarkers to inform and accelerate your early drug development.
Round tables will be led by key leaders in biomarker development and analysis, for provocative discussions with colleagues on the latest industry trends and challenges. Topics range from imaging biomarkers and the early use of human pharmacodynamic models of disease state, to new and automated laboratory platforms, companion diagnostics and regulatory expectations. In addition, therapeutic areas of focus will include Cognition, Pain, Oncology, and Inflammation.
Participants will be given their choice of three of the four round table discussion to select in advance of the event. A selection of drinks and canapés will be served.
| Date & Time: Thursday 25 October 2012, 16:00-18:30 Venue: Radisson Blu Royal Hotel, Hammerichsgade 1, Copenhagen, Denmark Price: MVA members free of charge (no-show/late cancellation fee DKK 1.000 ex VAT) Non-members DKK 2.500 ex. VAT, will be invoiced prior to the seminar. Become a member here Parking: At Radisson Blu Royal Hotel is free of charge for participants. Register: To register please go to the bottom of this page. |
In collaboration with: |
Program
| 16:00 | Registration, networking & canapés |
| 16:45 | First round table discussion |
| 17:15 | Second round table discussion |
| 17:45 | Third round table discussion |
| 18:10 | Questions & Answers |
| 18:30 | End of meeting |
Speakers and leading round table
John Connell, Vice President Pharmacodynamics, IDS
TOPIC: The Use of Human Pharmacodynamic Models of Disease State to Accelerate Early Clinical Development
Thomas McCloskey, Director Cell Biology Res&Dev, ICL R&D
TOPIC: Flow Cytometry and Clinical Trials
John Allinson, Vice President Biomarker Lab Services
TOPIC: Laboratory Biomarkers – New and/or Automated Platforms, companion diagnostics and FDA Expectations
Valerie Treyer, Director Med & Scientific Affairs
TOPIC: Use of imaging biomarker in early phase studies, personalized imaging at its best
About ICON plc
Founded in 1990, ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. ICON specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to phase I-IV clinical studies.
ICON has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated full service solution CRO.
Register
Please register by filling in the form below, latest Monday 22 October.
We use the input data as it is written for name tags and list of participants, and the email for further information prior to the Boost Seminar.
Registration has been closed